Lanzhou University First Hospital Nursing Department (School of Nursing Lanzhou University).
The First Clinical Medical College of Lanzhou University.
Medicine (Baltimore). 2021 Apr 2;100(13):e25380. doi: 10.1097/MD.0000000000025380.
Taijiquan, as a supplementary and alternative method, has attracted more and more attention in the treatment of breast cancer. But up to now, no systematic review has been performed to evaluate the efficacy of Taijiquan in the treatment of breast cancer. In this study, Cochrane systematic review method will be used to evaluate the effect of Taijiquan in the rehabilitation process of breast cancer patients after treatment.
PubMed, Embase. com, the Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang, and SinoMed will be searched to identify relevant studies up to May 31, 2021. We will include randomized controlled trials (RCTs) of the application of Taijiquan in post-treatment breast cancer patients. We will use the Cochrane bias risk assessment tool to assess the quality of included RCTs. We will use Stata 13.0 to perform pairwise meta-analyses using the inverse variance method. Subgroup analyses and sensitivity analyses will be conducted to investigate the sources of heterogeneity.
The results of this study will be published in a peer-reviewed journal.
This study will comprehensively evaluate the efficacy of Taijiquan in the rehabilitation treatment of breast cancer. The results of this study will provide high-quality evidence to support clinical practice and guidelines development.
太极拳作为一种补充和替代疗法，在乳腺癌的治疗中越来越受到关注。但迄今为止，尚未进行系统评价来评估太极拳在乳腺癌治疗中的疗效。本研究将采用 Cochrane 系统评价方法来评估太极拳在乳腺癌患者治疗后康复过程中的作用。
检索 PubMed、Embase.com、Cochrane 中央对照试验注册库（CENTRAL）、Web of Science、中国知网（CNKI）、万方和中国生物医学文献服务系统（SinoMed），以获取截至 2021 年 5 月 31 日的相关研究。我们将纳入太极拳在乳腺癌患者治疗后应用的随机对照试验（RCT）。我们将使用 Cochrane 偏倚风险评估工具来评估纳入 RCT 的质量。我们将使用 Stata 13.0 采用倒数方差法进行两两荟萃分析。将进行亚组分析和敏感性分析，以探讨异质性的来源。
本研究的结果将发表在同行评议的期刊上。
本研究将全面评估太极拳在乳腺癌康复治疗中的疗效。本研究的结果将为临床实践和指南制定提供高质量的证据。
